Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1335304
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1335304
Neurological Biomarkers Market with COVID-19 Impact Analysis, By Type, By Application, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 318 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Neurological biomarkers market size was valued at USD 5,607.9 Million in 2022, expanding at a CAGR of 15.8% from 2023 to 2030.
Neurological biomarkers are the biomarkers used for calculating and evaluating a symptom or method for obtaining a pharmacological response to a particular treatment. Additionally, they are extensively used for the identification of various diseases, such as autism, Parkinson's disease, and depression. Moreover, the general types of neurological biomarkers are metabolomics imaging, genomics, and proteomics.
Neurological Biomarkers Market- Market Dynamics:
- Increasing Technological Advancements and Increasing Development of Precision Medicine.
- Increasing advancements in biomarkers, including biomarker signatures, make neurological diseases more treatable. As a result, in faster drug development, early diagnosis, and noninvasive testing. In addition, digital biomarkers provide various pharmaceutical companies as well as supplemental information to conclude the decisions for clinical trials. This, in turn, such factors fuel the market growth of neurological biomarkers. Moreover, in personalized medicine, biomarker research in neurodegenerative disease is a large advancing area. Various molecules have been associated and assessed with varied neurodegenerative disorders. Thus, the biopharmaceutical industry is impacted by the evolution of precision medicine. From biopharma to diagnostics companies' different players with several functions, including commercial operations to research and development will observe a huge change. This is attributed to positively impacting the market growth. However, protracted biomarker development cycles and high startup costs are expected to restrain market growth. Furthermore, the wide presence of organizations offering funds at numerous stages of research is expected to provide a great opportunity for market expansion. To support research associated with health disparities in Alzheimer's and brain aging, the National Institutes of Health (NIH) is providing additional funds, therefore this factor may fuel the market growth.
Neurological Biomarkers Market- Key Insights:
- As per the analysis shared by our research analyst, the global neurological biomarkers market is estimated to grow annually at a CAGR of around 15.8% over the forecast period (2023-2030)
- The neurological biomarkers industry is projected to grow at a significant rate due to the increasing advancements in biomarkers
- Based on type segmentation, genomic was predicted to show maximum market share in the year 2022
- Based on application segmentation, Alzheimer's disease was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Neurological Biomarkers Market- Segmentation Analysis:
- The global neurological biomarkers market is segmented on the basis of type, application, end-use, and region.
- The market is divided into four categories based on type: imaging, proteomic, genomic, metabolomic, and others. The genomic segment is likely to maintain its dominance during the forecast period. The segment provides various opportunities for the development of personalized medicines and diagnostics based on an individual's predisposition to the disease & specific genetic variations. Additionally, methods used for the identification of the presence or studying genomic biomarkers for detecting disease-associated DNA sequence variants include whole-genome association studies using Single Nucleotide Polymorphisms (SNPs), array Comparative Genomic Hybridization (CGH), whole-genome resequencing, and gene expression profiling.
- The market is divided into four categories based on application: multiple sclerosis, Alzheimer's disease, autism spectrum disorder, Parkinson's disease, and others. The Alzheimer's disease segment is expected to dominate the market. The growth is attributed to the increasing disease burden and product availability for clinical use, including imaging biomarkers-amyloid PET tracers for diagnosis. Moreover, non-profit and government organizations are offering a plethora of research opportunities that may boost market growth.
- The market is divided into three categories based on end-use: research organizations, hospital & hospital laboratories, independent clinical diagnostic centers, and others. The hospital & hospital laboratories segment is likely to maintain its dominance over the forecast period due to a rise in hospitalization. Additionally, hospital facilities are enhanced by the ongoing development of healthcare infrastructure. Many blood-based biomarker assays are owned by hospitals and utilized in significant volumes. Moreover, research organizations are accounted to the grow at the fastest owing to the rising adoption of biomarkers ambulatory Surgery Centers (ASCs) and pharmaceutical companies for drug discovery & development
Neurological Biomarkers Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Neurological Biomarkers Market- Competitive Landscape:
The rise in the prevalence of neurological diseases like dementia, brain tumors, migraines, epilepsy, and Alzheimer's disease is attributed to the growth of the market. Additionally, in neurological disorders, the factors such as the requirement for early diagnosis and technological advancements are contributing to market growth. Moreover, strategies adopted by market players that allow them to utilize led to the development of innovative products and enhance their supply chain. Based on this, the strategies include the launch of various products, collaboration, agreement, acquisition, and technological advancements to gain a foothold in the market. For instance, in August 2020, Enigma Biomedical Group announced signing an agreement to License Novel Neuro Imaging Biomarkers from Janssen. Additionally, these biomarkers hold great promise to offer essential new tools in the advancement of our understanding of a range of neurodegenerative diseases, including Alzheimer 's disease and other dementias.
Recent Developments:
For instance, in April 2021, Quanterix Corp. introduced a webinar with top industry professionals to discuss neurological advancements related to the ultra-sensitive measurement of pTau181, pTau217, pTau231, and other neurological biomarkers.
Key features of the study:
- This proposed research study on neurological biomarkers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
- The report provides the client the latest up-to-date and trending insights about the neurological biomarkers market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for neurological biomarkers market.
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the neurological biomarkers market.
- Impact of COVID-19 on neurological biomarkers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on neurological biomarkers market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the neurological biomarkers market, we have also included competitive landscape and key innovator analysis for the neurological biomarkers market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the neurological biomarkers market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global neurological biomarkers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS
- PERKINELMER INC.
- Abbott Laboratories
- Quanterix
- Thermo Fisher Scientific, Inc.
- Neurobio
- Banyan Biomarkers, Inc.
- Bio-Rad Laboratories, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- Merck & Co., Inc.
- DiaGenic ASA
- Johnson & Johnson Services, Inc.
- Myriad Genetics, Inc.
GLOBALNEUROLOGICAL BIOMARKERS MARKET, BY TYPE
- Imaging
- Proteomic
- Genomic
- Metabolomic
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION
- Multiple Sclerosis
- Alzheimer's Disease
- Autism Spectrum Disorder
- Parkinson's Disease
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE
- Research Organizations
- Hospital & Hospital Laboratories
- Independent Clinical Diagnostic Centers
- Others
GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1582
Table of Contents
1. Neurological Biomarkers Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Neurological Biomarkers Market Snippet by Type
- 2.1.2. Neurological Biomarkers Market Snippet by Application
- 2.1.3. Neurological Biomarkers Market Snippet by End-use
- 2.1.4. Neurological Biomarkers Market Snippet by Country
- 2.1.5. Neurological Biomarkers Market Snippet by Region
- 2.2. Competitive Insights
3. Neurological Biomarkers Key Market Trends
- 3.1. Neurological Biomarkers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Neurological Biomarkers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Neurological Biomarkers Market Opportunities
- 3.4. Neurological Biomarkers Market Future Trends
4. Neurological Biomarkers Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Neurological Biomarkers Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Neurological Biomarkers Market Landscape
- 6.1. Neurological Biomarkers Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Neurological Biomarkers Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
- 7.1.2. Imaging
- 7.1.3. Proteomic
- 7.1.4. Genomic
- 7.1.5. Metabolomic
- 7.1.6. Others
8. Neurological Biomarkers Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
- 8.1.2. Multiple Sclerosis
- 8.1.3. Alzheimer's Disease
- 8.1.4. Autism Spectrum Disorder
- 8.1.5. Parkinson's Disease
- 8.1.6. Others
9. Neurological Biomarkers Market - By End-use
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
- 9.1.2. Research Organizations
- 9.1.3. Hospital & Hospital Laboratories
- 9.1.4. Independent Clinical Diagnostic Centers
- 9.1.5. Others
10. Neurological Biomarkers Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Neurological Biomarkers Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Neurological Biomarkers Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Neurological Biomarkers Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Neurological Biomarkers Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Neurological Biomarkers Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Neurological Biomarkers Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. PERKINELMER INC.
- 11.2.2. Abbott Laboratories
- 11.2.3. Quanterix
- 11.2.4. Thermo Fisher Scientific, Inc.
- 11.2.5. Neurobio
- 11.2.6. Banyan Biomarkers, Inc.
- 11.2.7. Bio-Rad Laboratories, Inc.
- 11.2.8. F. HOFFMANN-LA ROCHE LTD.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. DiaGenic ASA
- 11.2.11. Johnson & Johnson Services, Inc.
- 11.2.12. Myriad Genetics, Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1582
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Neurological Biomarkers Market: Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Neurological Biomarkers Market, by Type2018-2030 (USD Million)
- TABLE Neurological Biomarkers Market: ApplicationSnapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Neurological Biomarkers Market, by Application2018-2030 (USD Million)
- TABLE Neurological Biomarkers Market: End-use Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End-use
- TABLE Global Neurological Biomarkers Market, by End-use 2018-2030 (USD Million)
- TABLE Neurological Biomarkers Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Neurological Biomarkers Market, by Region 2018-2030 (USD Million)
- TABLE North America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE North America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE North America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE North America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
- TABLE Europe Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE EuropeNeurological Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
- TABLE Asia Pacific Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
- TABLE Latin America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
- TABLE Middle East and Africa Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
List of Figures
- FIGURE Neurological Biomarkers Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Type segment market share analysis, 2022&2030
- FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Application segment market share analysis, 2022&2030
- FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE End-use segment market share analysis, 2022&2030
- FIGURE End-use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022&2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Neurological Biomarkers Market share and leading players, 2022
- FIGURE Europe Neurological Biomarkers Market share and leading players, 2022
- FIGURE Asia Pacific Neurological Biomarkers Market share and leading players, 2022
- FIGURE Latin America Neurological Biomarkers Market share and leading players, 2022
- FIGURE Middle East and Africa Neurological Biomarkers Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Neurological Biomarkers Market share analysis by country, 2022
- FIGURE Germany Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Neurological Biomarkers Market share analysis by country, 2022
- FIGURE India Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Neurological Biomarkers Market share analysis by country, 2022
- FIGURE Brazil Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Neurological Biomarkers Market share analysis by country, 2022
- FIGURE Saudi Arabia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.